查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439314

血管闭合装置 - 全球市场回顾、竞争格局、市场预测 (2030)

Vascular Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球血管闭合器械市场规模预计2023年将达到11.1亿美元，2030年将达到15.9亿美元，2024-2030年预测期间复合年增长率为6.18%。诸如心肌梗塞等心血管疾病的盛行率不断上升、与肥胖和高血压等心血管疾病相关的危险因子的盛行率不断上升、人口老化的加剧以及微创手术的快速普及等因素预计将推动这一趋势的发展。血管闭合器械市场。

血管闭合装置市场动态

由于全球心血管疾病盛行率不断上升，血管闭合装置市场的需求不断增加。根据世界卫生组织 (WHO) (2023) 提供的数据，心血管疾病 (CVD) 是全球主要死亡原因，每年估计夺走 1,790 万人的生命。此外，同一世界卫生组织数据显示，超过五分之四的心血管疾病相关死亡是由中风和心臟病引起的，其中三分之一的死亡发生在 70 岁以下的早期死亡中。估计。

根据欧洲心臟学会（ESC）（2023）的数据，心血管疾病（CVD）每年导致欧洲 390 万人死亡，欧盟（EU）超过 180 万人死亡。它约占欧洲所有死亡人数的 45%，占欧盟的 37%。

常见的心血管疾病包括冠状动脉心臟病、中风、週边性心臟病、心臟衰竭等。

此外，不健康的生活习惯，例如久坐的生活方式，导致所有年龄层的肥胖盛行率增加。根据世界卫生组织（WHO）发布的肥胖情况说明书（2023年），超过19亿18岁以上成年人超重，其中6.5亿人肥胖。肥胖被认为是发生心血管疾病的主要危险因子之一。据认为，肥胖增加会增加血压并增加心血管疾病的发生率。

因此，心血管疾病和相关危险因子的日益普及导致对用于诊断和治疗目的的介入心臟手术（例如血管摄影和血管成形术）的需求增加。因此，对血管闭合装置的需求不断增加，因为它们有助于以省时的方式密封进入部位。

此外，微创手术的日益普及（例如新的发展）继续推动 VCD 的使用。目前的趋势集中在开发能够安全有效地闭合大口径股动脉切口的设备。随着经导管主动脉瓣修復术和经皮血管内动脉瘤修復术变得越来越普遍，人们有很大的动力去开发和证明简单而有效的 VCD 的实用性。

然而，与血管闭合装置相关的併发症以及血管闭合装置在闭合大直径穿刺时的限制可能成为血管闭合装置市场成长的某些限制因素。

血管闭合装置市场区隔分析

在血管闭合装置市场的产品领域，血管装置的动态接近器类别预计将在血管闭合装置市场中占据重要的收入份额。这归因于其优于静态接近器的质量，与需要更长时间才能停止血流的静态接近器相比，它可以立即闭合血管。动态逼近器进一步分为基于缝合的、基于夹子的和压缩辅助设备。

此外，由于基于生物材料的设备日益普及，静态近似器类别预计在预测期内将呈现出血管闭合设备的更快成长。

预计北美将主导整个血管闭合装置市场。

在所有地区中，预计北美将占据血管闭合装置市场的主要市场份额。由于心血管疾病及相关危险因子的高盛行率、老年人口的增加、疾病管理意识高以及购买此类设备的能力等，预计北美将占据主导市场份额。

本报告提供了全球血管闭合装置市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章血管闭合装置市场报告简介

第二章血管闭合装置市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估
  • 财务基准

第三章 法规与专利分析

  • 美国
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
  • 日本

第四章血管闭合器械市场关键因素分析

  • 血管闭合装置市场驱动因素
    • 心血管疾病增加
    • 与 CVD 相关的危险因子盛行率增加
    • 微创手术越来越受欢迎
    • 产品创新活动快速增加
  • 血管闭合器械市场的限制因素与挑战
    • 与血管闭合装置相关的併发症
    • 血管闭合装置在闭合大直径穿孔时的局限性
  • 血管闭合装置市场机遇
    • 生物可吸收血管闭合器的研製

第五章血管闭合装置市场的波特五力分析

第六章 COVID-19对血管闭合器械市场的影响分析

第七章血管闭合器市场布局

  • 按产品类型
    • 动态逼近器
    • 静态逼近器
    • 其他
  • 按访问类型
    • 大腿
    • 半径
  • 按最终用户
    • 医院
    • 门诊手术中心
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第八章血管闭合装置市场：全球公司份额分析 - 3至5家主要公司

第九章血管闭合装置市场公司与产品概况

  • Abbott
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Medtronic
  • Cardinal Health
  • Cardival Medical, Inc
  • Merit Medical systems
  • Morris Innovative
  • TZ Medical
  • Vasorum Ltd
  • Tricol Biomedical
  • Vivasure Medical Ltd.
  • Transluminal Technologies
  • W. L. Gore & Associates, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Gem srl

第10章 项目方法

  • 二次资料
  • 一次资料
  • 数据三角测量
  • 主要专家意见

第11章 KOL观点

第12章 DelveInsight服务内容

第13章 免责声明

第 14 章关于 DelveInsight

Product Code: DIMDCL0106

Vascular Closure Devices Market By Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based And Bioabsorbable Plugs], and Others), By Access (Femoral And Radial), and By End User (Hospitals & Clinics, Ambulatory Surgical Centers, ad Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of cardiovascular diseases such as heart strokes and increasing prevalence of obesity.

Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030. Factors such as the growing prevalence of cardiovascular disorders such as heart strokes, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.

Vascular Closure Devices Market Dynamics:

The vascular closure devices market is witnessing an increase in demand due to the rising prevalence of cardiovascular diseases the globe. As per the data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of death across the globe, accounting for an estimated 17.9 million loss of lives each year. Furthermore, the same data by the WHO presented that over four out of five deaths related to cardiovascular diseases list strokes and heart attacks as the main cause, and one-third of these deaths are estimate to occur prematurely in people below 70 years of age.

According to the data provided by the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the European Union.

Some of the common cardiovascular diseases include coronary heart disease, strokes, peripheral heart disease, and heart failure among others.

Furthermore, the unhealthy lifestyle such as sedentary lifestyle has led to the increased prevalence of obesity in the world across all age groups. According to the factsheet provided by the World Health Organization on Obesity (2023), over 1.9 billion adults in the age group of 18 and above were overweight, out of which 650 million people were obese. Obesity is considered as one of the major risk factors for the development of cardiovascular diseases. It has been observed that the increase body mass index results in the increase in blood pressures and rates of cardiovascular diseases.

Therefore, the increase in the prevalence of cardiovascular diseases and the associated risk factors have led to the growth in demand for interventional cardiac procedures for both diagnostic and treatment purposes such as angiography and angioplasty. Therefore, the need for vascular closure devices is witnessing an increase as they help in the sealing of the access site in a time-efficient manner.

Moreover, the rising popularity of minimally invasive procedures such as new developments continue to advance the utilization of VCDs. Current trends are focused on developing devices that can safely and efficiently close large-caliber femoral arteriotomies. As trans-catheter aortic valve repair and percutaneous endovascular aneurysm repair become commonplace, there will be tremendous incentive to develop and prove the utility of a simple but effective VCD.

However, complications associated with the vascular closure devices, and limitations of vascular closure devices in closing large bore punctures may prove to be certain restraints to the vascular closures devices market growth.

Vascular Closure Devices Market Segment Analysis:

Vascular Closure Devices Market by Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based and Bioabsorbable Plugs], and Others), by Access (Femoral And Radial), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the vascular closure devices market, the active approximators category of the vascular devices is expected to amass the significant revenue share in the vascular closure devices market. This can be attributed to their advantageous quality over passive approximators in terms of providing immediate vascular closure compared to passive approximators that take time in ceasing the blood flow. The active approximators are further segmented into suture-based, clip-based, and compression-assist devices.

Furthermore, the passive approximators category is predicted to witness a faster growth in the vascular closure devices in the forecast period due to the growing popularity of the biomaterial-based devices.

North America is expected to dominate in the overall Vascular Closure Devices Market:

Among all the regions, North America is expected to account for the significant market share in the vascular closure devices market. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.

Heart diseases in an umbrella term which encompasses numerous indications such as acute coronary syndrome, atherosclerosis, congestive heart failure among others. As per the information provided by the Centers for Disease Control and Prevention (2023), some of the key risk factors associated with heart diseases are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

Furthermore, as per the data provided by the Canadian Institute for Health Information, in 2020, about 2.4 million Canadians suffered from heart disease and was considered to be the second leading cause of death in the country. Therefore, this may result in an increase in the patient population suffering from heart diseases which may in turn increase in the demand for cardiac interventional procedures, thereby boosting the demand for vascular closure devices.

Moreover, the well-established patient care system along with awareness among patients and caregivers regarding the importance of diagnostic and therapeutic interventional procedures is further expected to propel the North American vascular closure devices market growth.

The Asia-Pacific region is expected to witness a significant growth in the vascular closure devices market in the forecast period which can ascribed to the fact that there has been constant efforts in improving healthcare access to the population in the countries in the region and the improvement in disposable income which has further been instrumental in more people opting for healthcare services. All these factors are collectively expected to contribute in the increase in the number of people availing routine diagnostic and treatment services for various diseases such as cardiovascular diseases wherein angiography procedures are majorly used. This is in turn, is expected to drive the demand for vascular closure devices in the region as these devices find application in the sealing of access point entry of the catheter, thereby boosting the growth of the vascular closure devices market in the forecast period.

Vascular Closure Devices Market Key Players:

Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl others.

Recent Developmental Activities in Vascular Closure Devices Market:

In July 2022, Vivasure Medical announced the development of PerQseal® Blue, the new investigational product which is under development. PerQseal Blue is designed specifically for suture less and fully absorbable large-bore venous vessel closure to be used in the percutaneous cardiovascular procedures, such trans-catheter mitral valve repair or replacement (TMVR) and trans-catheter tricuspid valve repair or replacement (TTVR).

In March 2022, CyndRx LLC finalized the pivotal CE Mark trial with the strong clinical outcomes for their vascular closure device AbsorbaSeal(TM) for evaluating the safety and efficacy of this polymer-based device.

In January 2022, Haemonetics Corporation entered into a definitive agreement to acquire Cardiva Medical Inc., a privately owned manufacturer of vascular closure systems.

Key Takeaways from the Vascular Closure Devices Market Report Study

Market size analysis for current vascular closure devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular closure devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global vascular closure devices market.

Various opportunities available for the other competitor in the vascular closure devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current vascular closure devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vascular closure devices market growth in the coming future?

Target Audience who can be benefited from this Vascular Closure Devices Market Report Study

Vascular Closure Devices products providers

Research organizations and consulting companies

Vascular Closure Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vascular closure devices

Various End-users who want to know more about the vascular closure devices market and latest technological developments in the vascular closure devices market.

Frequently Asked Questions for Vascular Closure Devices Market:

1. What is a Vascular Closure Device?

A vascular closure device are inserted at the end of a procedure with the aim to stop bleeding that occurs at the access point for the procedure in order to promote hemostasis and improve the ambulation time of patients.

2. What is the market for Global Vascular Closure Devices?

Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030.

3. What are the drivers for Global Vascular Closure Devices Market?

Factors such as the growing prevalence of cardiovascular disorders, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.

4. What are the key players operating in Global Vascular Closure Devices Market?

Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl, and others.

5. Which region has the highest share in Vascular Closure Devices market?

North America is expected to dominate the overall Vascular Closure Devices market during the forecast period, 2024 to 2030. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.

Table of Contents

1.Vascular Closure Devices Market Report Introduction

2. Vascular Closure Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. U.K.
  • 3.3. Japan

4. Vascular Closure Devices Market Key Factors Analysis

  • 4.1. Vascular Closure Devices Market Drivers
    • 4.1.1. Rising Number of Cardiovascular Diseases
    • 4.1.2. Increase in Prevalence of Risk Factors Associated with CVDs
    • 4.1.3. Growing Popularity of Minimally Invasive Procedures
    • 4.1.4. Surge in Product Innovation Activities
  • 4.2. Vascular Closure Devices Market Restraints and Challenges
    • 4.2.1. Complications Associated with Vascular Closure Devices
    • 4.2.2. Limitations of Vascular Closure Devices in Closing Large Bore Punctures
  • 4.3. Vascular Closure Devices Market Opportunities
    • 4.3.1. Development of Biosorbable Vascular Closure Devices

5. Vascular Closure Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular Closure Devices Market

7. Vascular Closure Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Active Approximators
      • 7.1.1.1. Suture-Based
      • 7.1.1.2. Clip-Based
      • 7.1.1.3. Assisted Compression Devices
    • 7.1.2. Passive Approximators
      • 7.1.2.1. Sealant or Gel-Based
      • 7.1.2.2. Biosorbable Plugs
    • 7.1.3. Others
  • 7.2. By Access Type
    • 7.2.1. Femoral
    • 7.2.2. Radial
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Vascular Closure Devices Market, by Product Type
      • 7.4.1.2. North America Vascular Closure Devices Market, by Access Type
      • 7.4.1.2. North America Vascular Closure Devices Market, by End User
      • 7.4.1.4. North America Vascular Closure Devices Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Vascular Closure Devices Market, by Product Type
      • 7.4.2.2. Europe Vascular Closure Devices Market, by Access Type
      • 7.4.2.3. Europe Vascular Closure Devices Market, by End User
      • 7.4.2.4. Europe Vascular Closure Devices Market, by Country
      • 7.4.2.2.1. France
      • 7.4.2.2.2. Germany
      • 7.4.2.2.3. United Kingdom
      • 7.4.2.2.4. Italy
      • 7.4.2.2.5. Spain
      • 7.4.2.2.6. Russia
      • 7.4.2.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Vascular Closure Devices Market, by Product Type
      • 7.4.3.2. Asia-Pacific Vascular Closure Devices Market, by Access Type
      • 7.4.3.3. Asia-Pacific Vascular Closure Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Vascular Closure Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Vascular Closure Devices Market, by Product Type
      • 7.4.4.2. RoW Vascular Closure Devices Market, by Access Type
      • 7.4.4.3. RoW Vascular Closure Devices Market, by End User
      • 7.4.4.4. RoW Vascular Closure Devices Market, by Country
      • 7.4.4.3.1. Middle East
      • 7.4.4.3.2. Africa
      • 7.4.4.3.3. South America

8. Vascular Closure Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Vascular Closure Devices Market Company and Product Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Teleflex Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Terumo Medical Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Medtronic
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cardinal Health
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Cardival Medical, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Merit Medical systems
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Morris Innovative
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. TZ Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Vasorum Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Tricol Biomedical
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Vivasure Medical Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Transluminal Technologies
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. W. L. Gore & Associates, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Meril Life Sciences Pvt. Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Gem srl
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Vascular Closure Devices Market
  • Table 3: Vascular Closure Devices Market in Global (2021-2030)
  • Table 4: Vascular Closure Devices Market in Global by Product Type (2021-2030)
  • Table 5: Vascular Closure Devices Market in Global by Access Type (2021-2030)
  • Table 6: Vascular Closure Devices Market in Global by End User (2021-2030)
  • Table 7: Vascular Closure Devices Market in Global by Geography (2021-2030)
  • Table 8: Vascular Closure Devices Market in North America (2021-2030)
  • Table 9: Vascular Closure Devices Market in North America by Product Type (2021-2030)
  • Table 10: Vascular Closure Devices Market in North America by Access Type (2021-2030)
  • Table 11: Vascular Closure Devices Market in North America by End User (2021-2030)
  • Table 12: Vascular Closure Devices Market in North America by Country (2021-2030)
  • Table 13: Vascular Closure Devices Market in the US (2021-2030)
  • Table 14: Vascular Closure Devices Market in Canada (2021-2030)
  • Table 15: Vascular Closure Devices Market in Mexico (2021-2030)
  • Table 16: Vascular Closure Devices Market in Europe (2021-2030)
  • Table 17: Vascular Closure Devices Market in Europe by Product Type (2021-2030)
  • Table 18: Vascular Closure Devices Market in Europe by Access Type (2021-2030)
  • Table 19: Vascular Closure Devices Market in Europe by End User (2021-2030)
  • Table 20: Vascular Closure Devices Market in Europe by Country (2021-2030)
  • Table 21: Vascular Closure Devices Market in France (2021-2030)
  • Table 22: Vascular Closure Devices Market in Germany (2021-2030)
  • Table 23: Vascular Closure Devices Market in the United Kingdom (2021-2030)
  • Table 24: Vascular Closure Devices Market in Italy (2021-2030)
  • Table 25: Vascular Closure Devices Market in Spain (2021-2030)
  • Table 26: Vascular Closure Devices Market in Russia (2021-2030)
  • Table 27: Vascular Closure Devices Market in Rest of Europe (2021-2030)
  • Table 28: Vascular Closure Devices Market in APAC (2021-2030)
  • Table 29: Vascular Closure Devices Market in APAC by Product Type (2021-2030)
  • Table 30: Vascular Closure Devices Market in APAC by Access Type (2021-2030)
  • Table 31: Vascular Closure Devices Market in APAC by End User (2021-2030)
  • Table 32: Vascular Closure Devices Market in APAC by Country (2021-2030)
  • Table 33: Vascular Closure Devices Market in China (2021-2030)
  • Table 34: Vascular Closure Devices Market in Japan (2021-2030)
  • Table 35: Vascular Closure Devices Market in India (2021-2030)
  • Table 36: Vascular Closure Devices Market in Australia (2021-2030)
  • Table 37: Vascular Closure Devices Market in South Korea (2021-2030)
  • Table 38: Vascular Closure Devices Market in Rest of APAC (2021-2030)
  • Table 39: Vascular Closure Devices Market in Rest of World (2021-2030)
  • Table 40: Vascular Closure Devices Market in RoW by Product Type (2021-2030)
  • Table 41: Vascular Closure Devices Market in RoW by Access Type (2021-2030)
  • Table 42: Vascular Closure Devices Market in RoW by End User (2021-2030)
  • Table 43: Vascular Closure Devices Market in RoW by Region (2021-2030)
  • Table 44: Vascular Closure Devices Market in Middle East (2021-2030)
  • Table 45: Vascular Closure Devices Market in Africa (2021-2030)
  • Table 46: Vascular Closure Devices Market in South America (2021-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis on Vascular Closure Devices Market

Figures 3: Vascular Closure Devices Market in Global (2021-2030)

Figures 4: Vascular Closure Devices Market in Global by Product Type (2021-2030)

Figures 5: Vascular Closure Devices Market in Global by Access Type (2021-2030)

Figures 6: Vascular Closure Devices Market in Global by End User (2021-2030)

Figures 7: Vascular Closure Devices Market in Global by Geography (2021-2030)

Figures 8: Vascular Closure Devices Market in North America (2021-2030)

Figures 9: Vascular Closure Devices Market in North America by Product Type (2021-2030)

Figures 10: Vascular Closure Devices Market in North America by Access Type (2021-2030)

Figures 11: Vascular Closure Devices Market in North America by End User (2021-2030)

Figures 12: Vascular Closure Devices Market in North America by Country (2021-2030)

Figures 13: Vascular Closure Devices Market in the US (2021-2030)

Figures 14: Vascular Closure Devices Market in Canada (2021-2030)

Figures 15: Vascular Closure Devices Market in Mexico (2021-2030)

Figures 16: Vascular Closure Devices Market in Europe (2021-2030)

Figures 17: Vascular Closure Devices Market in Europe by Product Type (2021-2030)

Figures 18: Vascular Closure Devices Market in Europe by Access Type (2021-2030)

Figures 19: Vascular Closure Devices Market in Europe by End User (2021-2030)

Figures 20: Vascular Closure Devices Market in Europe by Country (2021-2030)

Figures 21: Vascular Closure Devices Market in France (2021-2030)

Figures 22: Vascular Closure Devices Market in Germany (2021-2030)

Figures 23: Vascular Closure Devices Market in the United Kingdom (2021-2030)

Figures 24: Vascular Closure Devices Market in Italy (2021-2030)

Figures 25: Vascular Closure Devices Market in Spain (2021-2030)

Figures 26: Vascular Closure Devices Market in Russia (2021-2030)

Figures 27: Vascular Closure Devices Market in Rest of Europe (2021-2030)

Figures 28: Vascular Closure Devices Market in APAC (2021-2030)

Figures 29: Vascular Closure Devices Market in APAC by Product Type (2021-2030)

Figures 30: Vascular Closure Devices Market in APAC by Access Type (2021-2030)

Figures 31: Vascular Closure Devices Market in APAC by End User (2021-2030)

Figures 32: Vascular Closure Devices Market in APAC by Country (2021-2030)

Figures 33: Vascular Closure Devices Market in China (2021-2030)

Figures 34: Vascular Closure Devices Market in Japan (2021-2030)

Figures 35: Vascular Closure Devices Market in India (2021-2030)

Figures 36: Vascular Closure Devices Market in Australia (2021-2030)

Figures 37: Vascular Closure Devices Market in South Korea (2021-2030)

Figures 38: Vascular Closure Devices Market in Rest of APAC (2021-2030)

Figures 39: Vascular Closure Devices Market in Rest of World (2021-2030)

Figures 40: Vascular Closure Devices Market in RoW by Product Type (2021-2030)

Figures 41: Vascular Closure Devices Market in RoW by Access Type (2021-2030)

Figures 42: Vascular Closure Devices Market in RoW by End User (2021-2030)

Figures 43: Vascular Closure Devices Market in RoW by Region (2021-2030)

Figures 44: Vascular Closure Devices Market in Middle East (2021-2030)

Figures 45: Vascular Closure Devices Market in Africa (2021-2030)

Figures 46: Vascular Closure Devices Market in South America (2021-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis